◆ SpookStack

ry { i, FD-302a (Rev. 10-6-95) r 7 ] 279A-WF-222936-302 bé6 Continuation of FD-302 of i es On 01/29/2008 Page 4. anthrax-attacks of 2001 there was an across the board biodefense funding increase, including an increase in anthrax related research pertaining to therapeutics. who was familiar with many PIs in the Division at USAMRIID, noted that have transitioned well to the DTRA anthrax-therapeutics proposals. advised IVINS has no active proposals; however, IVINS possibly was an "extra-mural contracting officer," meaning a technical representative pertaining to anthrax-therapeutics. [ —__] indicated that there was probably some resistence from the _Pis in the Division to the DTRA system however, again indicated that [| appeazed to have demonstrated an ability to be able to transition. clarified that prior 2003, the various. ivision steering committees along with the recommendation of the MRMC staff decided how and to whom the various research funds would be dispersed. However, since 2003, DTRA has since taken over the Army's role in the management and oversight pertaining to the allocation of these research funds. DTRA has incorporated more structure and accountability in the entire process, via solicitations and proposals, including paying greater attention to prioritizing research initiatives based on research gaps identified at the DoD. Through observation and interview, ___—__—idjis further described as: . LAST NAME: FIRST NAME: MIDDLE INITIAL: SURNAME : RACE : SEX: DOB: HOME ADDRESS: EMPLOYER : WORK ADDRESS: WORK PHONE: b7c